Profile
Full Name
Apogee Therapeutics, Inc.Ticker Symbol
APGEExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 14, 2023Indexes
Not includedEmployees
196Key Details
Price
$31.80(+6.21%)
Market cap
$1.85B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.30(+1.79% YoY)
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Apogee Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 13, 25 Citigroup
BuyFeb 10, 25 Guggenheim
BuyDec 12, 24 Guggenheim
BuyDec 3, 24 Guggenheim
BuyDec 2, 24 Wedbush
OutperformNov 27, 24 Guggenheim
BuyNov 25, 24 Canaccord Genuity
BuyOct 25, 24 Wedbush
OutperformMay 10, 24 B of A Securities
BuyMar 6, 24 Jefferies
BuyInstitutional Ownership
- What is the ticker symbol for Apogee Therapeutics?
- Does Apogee Therapeutics pay dividends?
- What sector is Apogee Therapeutics in?
- What industry is Apogee Therapeutics in?
- What country is Apogee Therapeutics based in?
- When did Apogee Therapeutics go public?
- Is Apogee Therapeutics in the S&P 500?
- Is Apogee Therapeutics in the NASDAQ 100?
- Is Apogee Therapeutics in the Dow Jones?
- When was Apogee Therapeutics's last earnings report?
- When does Apogee Therapeutics report earnings?
- Should I buy Apogee Therapeutics stock now?
What is the ticker symbol for Apogee Therapeutics?
The ticker symbol for Apogee Therapeutics is NASDAQ:APGE
Does Apogee Therapeutics pay dividends?
No, Apogee Therapeutics does not pay dividends
What sector is Apogee Therapeutics in?
Apogee Therapeutics is in the Healthcare sector
What industry is Apogee Therapeutics in?
Apogee Therapeutics is in the Biotechnology industry
What country is Apogee Therapeutics based in?
Apogee Therapeutics is headquartered in United States
When did Apogee Therapeutics go public?
Apogee Therapeutics's initial public offering (IPO) was on July 14, 2023
Is Apogee Therapeutics in the S&P 500?
No, Apogee Therapeutics is not included in the S&P 500 index
Is Apogee Therapeutics in the NASDAQ 100?
No, Apogee Therapeutics is not included in the NASDAQ 100 index
Is Apogee Therapeutics in the Dow Jones?
No, Apogee Therapeutics is not included in the Dow Jones index
When was Apogee Therapeutics's last earnings report?
Apogee Therapeutics's most recent earnings report was on Mar 3, 2025
When does Apogee Therapeutics report earnings?
The next expected earnings date for Apogee Therapeutics is May 13, 2025
Should I buy Apogee Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions